Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies von Kerns, S Jordan, Belgur, Chaitra, Petropolis, Debora, Kanellias, Marianne, Barrile, Riccardo, Sam, Johannes, Weinzierl, Tina, Fauti, Tanja, Freimoser-Grundschober, Anne, Eckmann, Jan, Hage, Carina, Geiger, Martina, Ng, Patrick Ray, Tien-Street, William, Manatakis, Dimitris V, Micallef, Virginie, Gerard, Regine, Bscheider, Michael, Breous-Nystrom, Ekaterina, Schneider, Anneliese, Giusti, Anna Maria, Bertinetti-Lapatki, Cristina, Grant, Heather Shannon, Roth, Adrian B, Hamilton, Geraldine A, Singer, Thomas, Karalis, Katia, Moisan, Annie, Bruenker, Peter, Klein, Christian, Bacac, Marina, Gjorevski, Nikolce, Cabon, Lauriane

Volltext

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors von Bacac, Marina, Fauti, Tanja, Sam, Johannes, Colombetti, Sara, Weinzierl, Tina, Ouaret, Djamila, Bodmer, Walter, Lehmann, Steffi, Hofer, Thomas, Hosse, Ralf J, Moessner, Ekkehard, Ast, Oliver, Bruenker, Peter, Grau-Richards, Sandra, Schaller, Teilo, Seidl, Annette, Gerdes, Christian, Perro, Mario, Nicolini, Valeria, Steinhoff, Nathalie, Dudal, Sherri, Neumann, Sebastian, von Hirschheydt, Thomas, Jaeger, Christiane, Saro, Jose, Karanikas, Vaios, Klein, Christian, Umaña, Pablo

Volltext

Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose von Ferrara, Claudia, Grau, Sandra, Jäger, Christiane, Sondermann, Peter, Brünker, Peter, Waldhauer, Inja, Hennig, Michael, Ruf, Armin, Rufer, Arne Christian, Stihle, Martine, Umaña, Pablo, Benz, Jörg

Volltext

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxic... von Mössner, Ekkehard, Brünker, Peter, Moser, Samuel, Püntener, Ursula, Schmidt, Carla, Herter, Sylvia, Grau, Roger, Gerdes, Christian, Nopora, Adam, van Puijenbroek, Erwin, Ferrara, Claudia, Sondermann, Peter, Jäger, Christiane, Strein, Pamela, Fertig, Georg, Friess, Thomas, Schüll, Christine, Bauer, Sabine, Dal Porto, Joseph, Del Nagro, Christopher, Dabbagh, Karim, Dyer, Martin J.S., Poppema, Sibrand, Klein, Christian, Umaña, Pablo

Volltext

Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity von Sum, Eva, Rapp, Moritz, Fröbel, Philipp, Le Clech, Marine, Dürr, Harald, Giusti, Anna Maria, Perro, Mario, Speziale, Dario, Kunz, Leo, Menietti, Elena, Brünker, Peter, Hopfer, Ulrike, Lechmann, Martin, Sobieniecki, Andrzej, Appelt, Birte, Adelfio, Roberto, Nicolini, Valeria, Freimoser-Grundschober, Anne, Jordaan, Whitney, Labiano, Sara, Weber, Felix, Emrich, Thomas, Christen, François, Essig, Birgit, Romero, Pedro, Trumpfheller, Christine, Umaña, Pablo

Volltext

Adaptor Anti-P329G CAR T Cells for Modular Targeting of AML von Stock, Sophia, Strzalkowski, Thaddaeus, Gottschlich, Adrian, Rohrbacher, Lisa, Fertig, Luisa, Menkhoff, Vivien D., Surowka, Marlena, Bruenker, Peter, Darowski, Diana, Endres, Stefan, von Bergwelt-Baildon, Michael, Subklewe, Marion, Klein, Christian, Kobold, Sebastian

Volltext

The Carbohydrate at Fc gamma RIIIa Asn-162: An element required for high affinity binding to non-fucosylated IgG glycoforms von Ferrara, Claudia, Stuart, Fiona, Sondermann, Peter, Bruenker, Peter, Umana, Pablo

Volltext

Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody von Geiger, Martina, Stubenrauch, Kay-Gunnar, Sam, Johannes, Richter, Wolfgang F., Jordan, Gregor, Eckmann, Jan, Hage, Carina, Nicolini, Valeria, Freimoser-Grundschober, Anne, Ritter, Mirko, Lauer, Matthias E., Stahlberg, Henning, Ringler, Philippe, Patel, Jigar, Sullivan, Eric, Grau-Richards, Sandra, Endres, Stefan, Kobold, Sebastian, Umaña, Pablo, Brünker, Peter, Klein, Christian

Volltext

First Infusion Reactions are Mediated by FcγRIIIb and Neutrophils von Weber, Felix, Breustedt, Daniel, Schlicht, Sonja, Meyer, Claas A., Niewoehner, Jens, Ebeling, Martin, Freskgard, Per-Ola, Bruenker, Peter, Singer, Thomas, Reth, Michael, Iglesias, Antonio

Volltext

P329G-CAR-J: a novel Jurkat-NFAT-based CAR-T reporter system recognizing the P329G Fc mutation von Darowski, Diana, Jost, Christian, Stubenrauch, Kay, Wessels, Uwe, Benz, Jörg, Ehler, Andreas, Freimoser-Grundschober, Anne, Brünker, Peter, Mössner, Ekkehard, Umaña, Pablo, Kobold, Sebastian, Klein, Christian

Volltext

Abstract C125: Preclinical pharmacodynamic biomarker and combination strategy of RG7386, a novel FAP-DR5 bispecific antibody for targeting solid tumors von Friess, Thomas, Broeske, Ann-Marie, Lechner, Stefanie, Abraham, Esther, Hoelzlwimmer, Gabriele, Sade, Hadassa, Bruenker, Peter, Krieter, Oliver

Volltext

Abstract 952: Induction of avidity-driven hyperclustering of DR5 by a new FAP-DR5 bispecific antibody (RG7386) leads to strong anti-tumor efficacy von Friess, Thomas, Lechner, Stefanie, Abraham, Esther, Broeske, Ann-Marie, Bader, Sabine, Roller, Andreas, Majety, Meher, Wartha, Katharina, Vega-Harring, Suzana, Sade, Hadassah, Krieter, Oliver, Bruenker, Peter

Volltext

Abstract 4573: A novel bispecific Fap-Dr5 antibody inducing potent and tumor-specific death receptor 5 (Dr5) activation by fibroblast activation protein (Fap)-dependent crosslinkin... von Wartha, Katharina, Weiser, Barbara, Friess, Thomas, Majety, Meher, Runza, Valeria, Herting, Frank, Weber, Thomas, Scheuer, Werner, Harring, Suzana Vega, Sade, Hadassah, Niu, Huifeng, Bruenker, Peter

Volltext

Abstract 2481: CEA TCB, a novel T-cell bispecific antibody with potent in vitro and in vivo antitumor activity against solid tumors von Bacac, Marina, Fauti, Tanja, Colombetti, Sara, Sam, Johannes, Nicolini, Valeria, Steinhoff, Nathalie, Ast, Oliver, Bruenker, Peter, Hosse, Ralf, Hofer, Thomas, Moessner, Ekkehard, Jaeger, Christiane, Saro, Jose, Karanikas, Vaios, Klein, Christian, Umana, Pablo

Volltext

ITOC2 – 037. CEA TCB, A novel T-cell bispecific antibody with potent in vitro and in vivo antitumour activity against solid tumours von Bacac, Marina, Fauti, Tanja, Colombetti, Sara, Sam, Johannes, Nicolini, Valeria, Steinhoff, Nathalie, Ast, Oliver, Bruenker, Peter, Hosse, Ralf, Hofer, Thomas, Moessner, Ekkehard, Jaeger, Christiane, Saro, Jose, Karanikas, Vaios, Klein, Christian, Umaña, Pablo

Volltext

A New Class of T-Cell Bispecific Antibodies for the Treatment of Multiple Myeloma, Binding to B Cell Maturation Antigen and CD3 and Showing Potent, Specific Antitumor Activity in M... von Vu, Minh Diem, Moser, Samuel, Delon, Camille, Latzko, Melanie, Gianotti, Reto, Lüoend, Remo, Friang, Chloé, Murr, Ramona, Duerner, Lydia Jasmin, Weinzierl, Tina, Fauti, Tanja, Bacac, Marina, Ast, Oliver, Freimoser-Grundschober, Anne, Rodriguez Diaz, Tea, Zielonka, Jörg, van Puijenbroek, Erwin, Hosse, Ralf, Bruenker, Peter, Mössner, Ekkehard, Klein, Christian, Umaña, Pablo, Strein, Klaus

Volltext

Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering von SCHUSTER, Manfred, UMANA, Pablo, MUDDE, Geert C, FERRARA, Claudia, BRÜNKER, Peter, GERDES, Christian, WAXENECKER, Gunter, WIEDERKUM, Susanne, SCHWAGER, Cornelia, LOIBNER, Hans, HIMMLER, Gottfried

Volltext

Abstract 486: Tumor-targeted, engineered IL-2 variant (IL-2v)-based immunocytokines for the immunotherapy of cancer von Klein, Christian, Waldhauer, Inja, Nicolini, Valeria, Dunn, Claire, Freimoser-Grundschober, Anne, Herter, Sylvia, Geven, Edwin, Boerman, Otto, Nayak, Tapan, van Puijenbroek, Erwin, Wittig, David, Moser, Samuel, Ast, Oliver, Bruenker, Peter, Hosse, Ralf, Lang, Sabine, Neumann, Sebastian, Kettenberger, Hubert, Grossmann, Adelbert, Gorr, Ingo, Evers, Stefan, Pisa, Pavel, Fretland, Jennifer, Levitsky, Victor, Gerdes, Christian, Bacac, Marina, Moessner, Ekkehard, Umaña, Pablo

Volltext

ANTIBODIES BINDING TO CSF1R AND CD3 von KLEIN, Christian, BRUENKER, Peter, GOTTSCHLICH, Adrian, KOBOLD, Sebastian

Volltext bestellen

IMPROVED FOLR1 PROTEASE-ACTIVATABLE T CELL BISPECIFIC ANTIBODIES von GEIGER, Martina, KLEIN, Christian, UMAÑA, Pablo, BRUENKER, Peter

Volltext bestellen